“Impact of the Modulator Elexacaftor Tezacaftor Ivacaftor (ETI) on the Complexity of Prescriptions and the Clinical Stage of Children and Adolescents With Cystic Fibrosis”. 2026. Research, Society and Development 15 (1): e7715150550. https://doi.org/10.33448/rsd-v15i1.50550.